Apr 28
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
Apr 27
|
Do you have the fat gene? This test could soon tell you
|
Apr 25
|
How tariffs impact pharma stocks
|
Apr 25
|
Novo Nordisk wins case to kick knockoff Ozempic off the market, but it may not last
|
Apr 25
|
FDA free to pursue semaglutide compounders after latest court ruling
|
Apr 25
|
Why Novo Nordisk Stock Dropped Today
|
Apr 25
|
The Best Stock to Buy With Less Than $60 in the Market Sell-Off
|
Apr 25
|
Trending tickers: Alphabet, Intel, Meta, Novo Nordisk and WPP
|
Apr 24
|
Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?
|
Apr 24
|
Novo Nordisk's stellar Wegovy-fuelled run of hiking sales guidance could be ending
|
Apr 23
|
Novo Nordisk Investors Just Got Terrible News. Should You Sell the Stock?
|
Apr 23
|
Is Eli Lilly Stock a Buy?
|
Apr 22
|
Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill
|
Apr 22
|
Novo Nordisk (NVO) Is a Good Short-Term Pick, Wealth Manager Says
|
Apr 22
|
Why Novo Nordisk Stock Popped Today
|
Apr 22
|
Think It's Too Late to Buy Novo Nordisk? Here's the Biggest Reason Why There's Still Time.
|
Apr 22
|
Trending tickers: Nvidia, Tesla, Roche, Novo Nordisk and Fresnillo
|
Apr 22
|
Novo shares down on Eli Lilly’s positive obesity pill data
|
Mar 14
|
Drugmakers agree to participate in second round of price negotiations
|
Mar 14
|
The Zacks Analyst Blog Highlights Novo Nordisk, Roche, Pfizer, Arvinas and J&J
|